Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $12000.0.

  • Nephros' Depreciation and Depletion changed 0.0% to $12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $54000.0, marking a year-over-year increase of 2272.73%. This contributed to the annual value of $46000.0 for FY2024, which is 1794.87% up from last year.
  • Per Nephros' latest filing, its Depreciation and Depletion stood at $12000.0 for Q3 2025, which was down 0.0% from $13000.0 recorded in Q2 2025.
  • In the past 5 years, Nephros' Depreciation and Depletion ranged from a high of $17000.0 in Q1 2022 and a low of $1000.0 during Q2 2023
  • For the 5-year period, Nephros' Depreciation and Depletion averaged around $10052.6, with its median value being $11000.0 (2022).
  • In the last 5 years, Nephros' Depreciation and Depletion tumbled by 9166.67% in 2023 and then surged by 110000.0% in 2024.
  • Quarter analysis of 5 years shows Nephros' Depreciation and Depletion stood at $16000.0 in 2021, then plummeted by 31.25% to $11000.0 in 2022, then decreased by 9.09% to $10000.0 in 2023, then grew by 20.0% to $12000.0 in 2024, then changed by 0.0% to $12000.0 in 2025.
  • Its Depreciation and Depletion stands at $12000.0 for Q3 2025, versus $13000.0 for Q2 2025 and $17000.0 for Q1 2025.